Symptoms and Diagnosis of Renal PHA1
At a Glance
Renal PHA1 causes a "salt-wasting crisis" in infants, typically appearing within the first two weeks of life with poor feeding, vomiting, and lethargy. Diagnosis is made by finding low sodium, high potassium, and extremely high aldosterone levels, and is confirmed through NR3C2 genetic testing.
The symptoms of Renal Pseudohypoaldosteronism Type 1 (Renal PHA1) often appear suddenly in the first few days or weeks of life [1][2]. Because the kidneys are losing salt, the body’s delicate chemical balance is disrupted, leading to a “salt-wasting crisis” that requires immediate medical attention.
Signs and Symptoms in Infancy
Most babies with Renal PHA1 appear healthy at birth but begin to show signs of distress between day 3 and day 14 of life [1][3]. The most common symptoms include:
- Poor Feeding and Failure to Thrive: Difficulty waking for feeds or not gaining weight as expected [4][5].
- Vomiting: Often mistaken for severe reflux or a stomach bug [4].
- Lethargy: Extreme sleepiness or a “floppy” appearance.
- Dehydration WARNING: Because the kidneys are actively flushing out salt and water, a baby with Renal PHA1 may continue to have plenty of wet diapers even when dangerously dehydrated. Do not rely on wet diapers as a sign of hydration. Instead, watch for rapid weight loss, extreme lethargy, or a sunken “soft spot” (fontanelle) on the head [6].
The Biochemical “Signature”
To diagnose Renal PHA1, doctors look for a specific pattern in the blood and urine. When the kidneys ignore aldosterone, they fail to keep sodium and fail to get rid of potassium [7][8]. This creates a unique biochemical profile:
- Hyponatremia (Low Sodium): The blood does not have enough salt because it is being flushed out in the urine [6][9].
- Hyperkalemia (High Potassium): Potassium levels rise to dangerous levels because the kidney cannot “pump” it out [6][7].
- Metabolic Acidosis: The blood becomes too acidic, which can make the baby breathe faster to compensate [9][10].
- High Renin and High Aldosterone: This is the “smoking gun.” In most conditions, if salt is low, the body makes more aldosterone to fix it. In Renal PHA1, the body makes massive amounts of aldosterone, but because the kidneys are resistant, the levels just keep climbing [11][7].
Renal PHA1 vs. CAH: The Newborn Screen False Alarm
When a newborn has low sodium and high potassium, doctors often first suspect Congenital Adrenal Hyperplasia (CAH) [9][12]. Many parents get a terrifying phone call about a positive Newborn Screening (NBS) test for CAH. However, both conditions look identical in early symptoms, but the treatments are completely different.
In CAH, the body cannot make enough hormones. In Renal PHA1, the body makes too much aldosterone but cannot use it [6][9]. Doctors use a test called 17-hydroxyprogesterone (17-OHP) to definitively rule out CAH; if this level is normal but aldosterone is extremely high, Renal PHA1 becomes the primary suspect [6][11].
Confirming with Genetics
While the blood tests point to the diagnosis, genetic testing of the NR3C2 gene provides the final confirmation [13][14]. This test looks for a “spelling error” in the gene that builds the kidney’s salt-saving receptors. Finding a mutation here confirms it is the renal-only form, which carries the reassuring news that the condition will likely resolve as the child grows [14][15].
Diagnosis Checklist
Review your child’s lab reports for these key markers. If any are missing, ask your doctor for the results.
- [ ] Sodium Level: (Looking for Low)
- [ ] Potassium Level: (Looking for High)
- [ ] Bicarbonate/CO2: (Looking for Low, indicating acidosis)
- [ ] Aldosterone: (Looking for Extremely High)
- [ ] Plasma Renin Activity (PRA): (Looking for Extremely High)
- [ ] 17-OHP: (Should be Normal to rule out CAH)
- [ ] NR3C2 Genetic Test: (Ordered or completed)
For more on how to manage these symptoms daily, see [-1](“Introduction to Renal PHA1”) or Treatment and Daily Management.
Common questions in this guide
What are the first signs of Renal PHA1 in a baby?
How is Renal PHA1 different from Congenital Adrenal Hyperplasia (CAH)?
What blood test results point to Renal PHA1?
What genetic test confirms Renal PHA1?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What was my child's 17-OHP level on the newborn screen, and does it definitively rule out Congenital Adrenal Hyperplasia?
- 2.Exactly how high were the aldosterone and renin levels compared to the normal range for a newborn?
- 3.Since we are waiting for genetic results, are there any physical signs that might suggest the systemic form instead of the renal form?
- 4.How frequently will we need to repeat these blood tests during the first year of life?
- 5.Was a urine culture or renal ultrasound performed to ensure a UTI or structural issue isn't causing these electrolyte imbalances?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (15)
- 1
Pseudohypoaldosteronism Type 1b in a Saudi Female Infant Due to Homozygous Variant Gene Mutation in SCNN1A: A Case Report.
Alquraishi A, Alshahrany A, Alasmari BG, et al.
Cureus 2024; (16(8)):e67165 doi:10.7759/cureus.67165.
PMID: 39295704 - 2
Systemic Pseudohypoaldosteronism Type 1 Due to a Novel Mutation in SCNN1B Gene: A Case Report.
Joshi K, Verma PK, Barman M
EJIFCC 2022; (33(3)):268-273.
PMID: 36447799 - 3
Systemic Pseudohypoaldosteronism Type I: A Case Report and Review of the Literature.
Nur N, Lang C, Hodax JK, Quintos JB
Case reports in pediatrics 2017; (2017()):7939854 doi:10.1155/2017/7939854.
PMID: 28484659 - 4
Neonatal pseudo-hypoaldosteronism type 1 with a novel NR3C2 gene variant.
Barsoum Z
Sudanese journal of paediatrics 2024; (24(2)):180-182 doi:10.24911/SJP.106-1671202254.
PMID: 39867278 - 5
A novel NR3C2 mutation in a Japanese patient with the renal form of pseudohypoaldosteronism type 1.
Tsunogai T, Miyata I, Kotake S, et al.
Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology 2016; (25(3)):111-4 doi:10.1297/cpe.25.111.
PMID: 27507913 - 6
A case of severe systemic type 1 pseudohypoaldosteronism with 10 years of evolution.
Coelho Almeida A, Bastos Gomes M, Martins SA, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2022; (35(11)):1448-1452 doi:10.1515/jpem-2022-0201.
PMID: 35918792 - 7
An infant with hyponatremia, hyperkalemia, and metabolic acidosis associated with urinary tract infection: Answers.
Atmis B, Turan İ, Melek E, Bayazit AK
Pediatric nephrology (Berlin, Germany) 2019; (34(10)):1739-1741 doi:10.1007/s00467-019-04254-2.
PMID: 31053900 - 8
Aldosterone deficiency with a hormone profile mimicking pseudohypoaldosteronism.
Martín-Rivada Á, Argente J, Martos-Moreno GÁ
Journal of pediatric endocrinology & metabolism : JPEM 2020; (33(11)):1501-1505.
PMID: 32809961 - 9
Novel SCNN1A gene splicing-site mutation causing autosomal recessive pseudohypoaldosteronism type 1 (PHA1) in two Italian patients belonging to the same small town.
Serra G, Antona V, D'Alessandro MM, et al.
Italian journal of pediatrics 2021; (47(1)):138 doi:10.1186/s13052-021-01080-x.
PMID: 34134742 - 10
Case Report: Compound Heterozygous SCNN1B Mutations Causing Pseudohypoaldosteronism Type 1B2 in Neonatal Twins.
Wang Z, Long L, Bi H
Molecular genetics & genomic medicine 2026; (14(1)):e70173 doi:10.1002/mgg3.70173.
PMID: 41457049 - 11
Pseudohypoaldosteronism in a Neonate Presenting as Life-Threatening Hyperkalemia.
Attia NA, Marzouk YI
Case reports in endocrinology 2016; (2016()):6384697 doi:10.1155/2016/6384697.
PMID: 26904317 - 12
In systemic pseudohypoaldosteronism type 1 skin manifestations are not rare and the disease is not transient.
Hanukoglu A, Hanukoglu I
Clinical endocrinology 2018; (89(2)):240-241 doi:10.1111/cen.13730.
PMID: 29702750 - 13
A novel mutation in the human mineralocorticoid receptor gene in a Japanese family with autosomal-dominant pseudohypoaldosteronism type 1.
Nishizaki Y, Hiura M, Sato H, et al.
Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology 2016; (25(4)):135-138 doi:10.1297/cpe.25.135.
PMID: 27780983 - 14
Two Japanese patients with the renal form of pseudohypoaldosteronism type 1 caused by mutations of NR3C2.
Morikawa S, Komatsu N, Sakata S, et al.
Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology 2015; (24(3)):135-8 doi:10.1297/cpe.24.135.
PMID: 26594094 - 15
When salt is needed to grow: Answers.
Conversano E, Romano S, Taddio A, et al.
Pediatric nephrology (Berlin, Germany) 2021; (36(5)):1131-1132 doi:10.1007/s00467-020-04647-8.
PMID: 32778955
This page explains the symptoms and diagnostic lab results for Renal PHA1 for educational purposes. Always consult your pediatric endocrinologist or nephrologist to interpret your child's specific lab tests and newborn screening results.
Get notified when new evidence is published on Renal pseudohypoaldosteronism type 1.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.